Morphogen-IX
MORPHOGEN-IX Limited is a drug discovery company founded in 2015 by Index Ventures to develop bone morphogenetic proteins
Funding reportedLast round: Series B
What company datasets say Morphogen-IX raised
Funding, as reported
Reported in all19.9Min the source's currency
Rounds2
Last roundSeries B
Last round dateDec 2018
Investors listed4
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Morphogen-IX in front of investors. Or tell us what we have wrong.